Literature DB >> 34897817

Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient.

G V Knechtl1, S M Seyed Jafari1, T Berger1, A Rammlmair1, L Feldmeyer1, L Borradori1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34897817     DOI： 10.1111/jdv.17868

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  5 in total

Review 1.  Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.

Authors:  Ajeet Singh; Sujana J Bharadwaj; Anju G Chirayath; Satyaki Ganguly
Journal:  J Cosmet Dermatol       Date:  2022-04-09       Impact factor: 2.189

Review 2.  Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.

Authors:  Yhojan Rodríguez; Manuel Rojas; Santiago Beltrán; Fernando Polo; Laura Camacho-Domínguez; Samuel David Morales; M Eric Gershwin; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2022-08-24       Impact factor: 14.511

Review 3.  Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies.

Authors:  Xueyi Huang; Xiaoqian Liang; Jiao Zhang; Hang Su; Yongfeng Chen
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

4.  New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination.

Authors:  Mina Almasi-Nasrabadi; Radha S Ayyalaraju; Ashish Sharma; Somaia Elsheikh; Shanti Ayob
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-14       Impact factor: 9.228

Review 5.  Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.

Authors:  Elena Calabria; Federica Canfora; Massimo Mascolo; Silvia Varricchio; Michele Davide Mignogna; Daniela Adamo
Journal:  Pathol Res Pract       Date:  2022-03-05       Impact factor: 3.309
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.